Key statistics
On Friday, Dr Reddy's Laboratories Ltd (RDY:NYQ) closed at 78.27, -7.33% below its 52-week high of 84.46, set on Aug 09, 2024.
52-week range
Open | 79.00 |
---|---|
High | 79.37 |
Low | 78.20 |
Bid | 77.42 |
Offer | 79.43 |
Previous close | 79.57 |
Average volume | 137.49k |
---|---|
Shares outstanding | 166.59m |
Free float | 166.00m |
P/E (TTM) | 19.73 |
Market cap | 13.16bn USD |
EPS (TTM) | 3.97 USD |
Annual div (ADY) | 0.4762 USD |
---|---|
Annual div yield (ADY) | 0.61% |
Div ex-date | Jul 30 2024 |
Div pay-date | Aug 12 2024 |
Data delayed at least 15 minutes, as of Oct 05 2024 00:00 BST.
More ▼
Press releases
- Dr. Reddy’s signs voluntary licensing agreement with Gilead Sciences to manufacture and commercialise Lenacapavir in India and other countries
- Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
- Dr. Reddy’s Receives Positive CHMP Opinion From European Medicines Agency for Its Proposed Rituximab Biosimilar
- Dr. Reddy’s Q1FY25 Financial Results